Adaptive Biotechnologies Corp. (ADPT)
15.93
+0.24
(+1.53%)
USD |
NASDAQ |
Dec 16, 16:00
16.08
+0.15
(+0.94%)
After-Hours: 20:00
Adaptive Biotechnologies Research and Development Expense (Annual): 94.33M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Akero Therapeutics, Inc. | 247.50M |
| Regeneron Pharmaceuticals, Inc. | 4.624B |
| Vertex Pharmaceuticals, Inc. | 3.630B |
| Zymeworks, Inc. | 134.62M |
| Krystal Biotech, Inc. | 53.57M |